U.S. Women Seeking Hormone-Free IUDs Come Up Shortnews2026-09-18T13:21:40+00:00September 18th, 2026|The New York Times|
A.I. Agents as ‘Co-Scientists’? This Lab Says They Could Speed Drug Research.news2026-09-17T18:08:24+00:00September 17th, 2026|The New York Times|
How Did a Heart Drug With So Much Promise Fall So Flat?news2026-09-11T16:31:02+00:00September 11th, 2026|The New York Times|
Early Data Indicates an A.I.-Generated Drug Could Slow Agingnews2026-09-07T15:12:14+00:00September 7th, 2026|The New York Times|
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologistsnews2026-09-04T23:42:44+00:00September 4th, 2026|The New York Times|
The Search for New Cures Is Brokennews2026-09-04T11:27:49+00:00September 4th, 2026|The New York Times|
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugsnews2026-08-31T16:43:57+00:00August 31st, 2026|The New York Times|
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Manynews2026-08-27T09:02:45+00:00August 27th, 2026|The New York Times|
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancernews2026-08-26T16:54:01+00:00August 26th, 2026|The New York Times|
Moderna’s Shift to Cancer Company Lifts Stock Up 177%news2026-08-20T14:23:51+00:00August 20th, 2026|The New York Times|
